Magdalena Tudrujek‐Zdunek
Medical University of Lublin(PL)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies
Most-Cited Works
- → Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study(2016)99 cited
- → Demographic and Clinical Overview of Hospitalized COVID-19 Patients during the First 17 Months of the Pandemic in Poland(2021)32 cited
- → Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6(2021)29 cited
- → Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study(2021)28 cited
- → Treatment of HCV infection in Poland at the beginning of the interferon‐free era—the EpiTer‐2 study(2018)27 cited
- → Changes of patient profile, treatment effectiveness and safety during 4 years access to interferon-free therapy for hepatitis C virus infection(2020)24 cited
- → Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study(2020)22 cited
- → Impact of Kidney Failure on the Severity of COVID-19(2021)22 cited
- → Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics(2021)19 cited
- → Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA(2020)19 cited